Kedrion warns MidEast conflict may disrupt plasma supplies to Iran

Italian biopharmaceutical company Kedrion said on Friday it may struggle to deliver vital plasma-based ​medicines to patients in Iran if disruption to ‌shipping through the Strait of Hormuz persists.